Thomas Leggett is Chief Financial Officer of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 0 shares of BDTX, which is worth approximately $0. The most recent transaction as insider was on Jan 08, 2021, when has been sold 3,000 shares (Common Stock) at a price of $33.94 per share, resulting in proceeds of $101,820. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Thomas Leggett Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2021
SELL
Open market or private sale
$101,820 $33.94 p/Share
3,000 Reduced 100.0%
0 Common Stock
Jan 08 2021
BUY
Exercise of conversion of derivative security
$32,580 $10.86 p/Share
3,000 Added 50.0%
3,000 Common Stock
Dec 08 2020
SELL
Open market or private sale
$100,980 $33.66 p/Share
3,000 Reduced 100.0%
0 Common Stock
Dec 08 2020
BUY
Exercise of conversion of derivative security
$32,580 $10.86 p/Share
3,000 Added 50.0%
3,000 Common Stock
Nov 09 2020
SELL
Open market or private sale
$98,880 $32.96 p/Share
3,000 Reduced 100.0%
0 Common Stock
Nov 09 2020
BUY
Exercise of conversion of derivative security
$32,580 $10.86 p/Share
3,000 Added 50.0%
3,000 Common Stock
Oct 08 2020
SELL
Open market or private sale
$100,590 $33.53 p/Share
3,000 Reduced 100.0%
0 Common Stock
Oct 08 2020
BUY
Exercise of conversion of derivative security
$32,580 $10.86 p/Share
3,000 Added 50.0%
3,000 Common Stock

Also insider at

STOK
Stoke Therapeutics, Inc. Healthcare
TL

Thomas Leggett

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on BDTX

Follow Black Diamond Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

News

Receive news related to Black Diamond Therapeutics, Inc.

Track Activities on BDTX